Navigation on this site is not optimized for your browser

Please use a recent version of Google Chrome, Mozilla Firefox, Safari or Microsoft Edge to get the most out of the experience.

Find a modern browser

Community M4PM - Tumours, organoids, spheroids in space

Imaris Snapshot

A “Tumours, Organoids and Spheroids in Space – Microgravity for Personalized Medicine (M4PM)” community will be comprised of member companies and academics that currently grow and utilise tumours, organoids, spheroids in pursuit of (personalised) medicine (terrestrially). The community is being initiated to bring together thought leaders in industry and academia to solve problems and advance personalised medicine through innovations in microgravity.

It is generally recognised within the research community that the optimisation and widespread implementation of 3D cell culture in vitro systems will revolutionise the drug development testing industry as a whole, by replacing in vivo models as the gold standard. 3D organoids and spheroids are currently grown through the utilisation of primary human tissue or pluripotent stem cells. These models exhibit multicellular self organisation and organ functionality, are capable of self renewal, and can remain stable for extended periods of time during cultivation.

However, many of the obstacles facing the development of 3D cell culturing platforms for drug discovery testing can be traced back to one issue: gravity. Using space to solve problems related to (personalised) medicine testing and discovery can be very effective not only with developing personalised (cancer) treatments, but also in increasing the rate of drug approval by using more relevant and realistic models than insufficient and inadequate (terrestrial) in vitro assays utilizing two-dimensional monolayers of (cancer) cells and animal models.

The “Tumours, Organoids and Spheroids in Space – Microgravity for Personalized Medicine (M4PM)” community is set up as part of the M4PM project by Blue Horizon and Space Applications Services and co-financed by the European Space Agency.

Download the charter below. If you would like to participate and become a member, please contact us.

Image credits: Wyss Institute (Kidney Organoid)

 

> 15
Key thought leaders engaged for the "Tumours, Organoids and Spheroids in Space - Microgravity for Personalized Medicine (M4PM)" community

This website uses cookies

We use cookies and similar technologies to adjust your preferences, analyse traffic and measure the effectiveness of campaigns. You consent to the use of our cookies by continuing to browse this website.
  • Analytics

    Google Tag Manager

    Cookie from Google Tag Manager allows us to set up and manage the sending of data to the different analysis services listed below (e.g. Google Analytics)

    Analytics

    Cookie from Google Analytics allows us to anonymously count visits, the sources of these visits as well as the actions taken on the site by visitors.

    Storage time 12 months

  • Essentials

    epic-cookie-prefs

    Cookie that remembers the user's choice of cookie preferences

    pll_language

    The server saves the language chosen by the user to display the correct version of the pages

    Storage time 12 months

This website uses cookies

We use cookies and similar techonologies to adjust your preferences, analyze traffic and measure the effectiveness of campaigns. You consent to the use of our cookies by continuing to browse this website.